Researchers from the University of South Carolina and the American Cancer Society analyzed data found in the National Cancer Database from 2004 to 2016. The main outcomes were survival at one, two and five years for 16 cancer types in 1.2 million patients, the article said.
The analysis showed younger uninsured cancer patients had significantly lower five-year survival rates than older insured patients. Uninsured patients ages 60 to 64 were also less likely to receive cancer treatments such as chemotherapy, radiotherapy and surgery than older Medicare patients.
The research comes after a long-standing argument for expansion of Medicare eligibility requirements.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
